Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,729 | -1,266 | -927 | N/A | N/A |
| Depreciation Amortization | 434 | 236 | 2 | N/A | N/A |
| Accounts receivable | -6 | -62 | -3 | N/A | N/A |
| Other Working Capital | 357 | 42 | 166 | N/A | N/A |
| Other Operating Activity | 735 | 526 | 208 | 0 | 0 |
| Operating Cash Flow | $-209 | $-523 | $-555 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -32 | -21 | N/A | N/A |
| Purchase Sale Intangibles | -40 | -45 | -36 | N/A | N/A |
| Other Investing Activity | -27 | -97 | -195 | 0 | 0 |
| Investing Cash Flow | $-31 | $-129 | $-215 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15 | 250 | 50 | N/A | N/A |
| Debt Issued | 15 | 319 | 17 | N/A | N/A |
| Common Stock Issued | 153 | 121 | 530 | N/A | N/A |
| Other Financing Activity | 8 | -21 | -52 | 0 | 0 |
| Financing Cash Flow | $191 | $669 | $545 | $N/A | $N/A |
| Beginning Cash Position | 65 | 48 | 273 | N/A | N/A |
| End Cash Position | 17 | 65 | 48 | N/A | N/A |
| Net Cash Flow | $-48 | $17 | $-225 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -209 | -523 | -555 | N/A | N/A |
| Capital Expenditure | -4 | -32 | -21 | N/A | N/A |
| Free Cash Flow | -212 | -555 | -575 | 0 | 0 |